Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):269–275. doi: 10.1097/QAI.0000000000003062

Table 1.

Baseline characteristics of index participants living with HIV who identified sexual and injecting partners in the Study of HIV/Hepatitis C, APS, and Phylogenetics for Persons Who Inject Drugs (SHARP)

Characteristic Total
(N=783)
Men
(N=402)
Women
(N=381)
n (%)
Age (years)
 18–25 74 (9.5) 25 (6.2) 49 (12.9)
 26–35 274 (35.0) 114 (28.4) 160 (42.0)
 36–45 318 (40.6) 185 (46.0) 133 (34.9)
 46–67 117 (14.9) 78 (19.4) 39 (10.2)
Relationship status
 Single 287 (36.7) 126 (31.3) 161 (42.3)
 Married or partnered 237 (30.3) 130 (32.3) 107 (28.1)
 Divorced or separated 184 (23.5) 104 (25.9) 80 (21.0)
 Widowed 75 (9.6) 42 (10.4) 33 (8.7)
Enrollment region
 Nairobi 452 (57.7) 189 (47.0) 263 (69.0)
 Coast 331 (42.3) 213 (53.0) 118 (31.0)
Recruitment Site Type (N=781*)
 Medication-assisted treatment centers** 159 (20.3) 76 (18.9) 83 (21.8)
 Needle and syringe programs 497 (63.5) 244 (60.7) 253 (66.4)
 Non-governmental organizations 125 (16.0) 80 (19.9) 45 (11.8)
Reported stable housing 675 (86.2) 339 (84.3) 336 (88.2)
Aware of HIV status at enrollment 709 (90.5) 368 (91.5) 341 (89.5)
Currently on antiretroviral therapy 625 (79.8) 336 (83.6) 289 (75.9)
Currently enrolled in a methadone program 176 (22.5) 112 (27.9) 64 (16.8)
Number of years injecting
 <5 441 (56.3) 175 (43.5) 266 (69.8)
 ≥5 337 (43.0) 225 (56.0) 112 (29.4)
Shared needles in past month 47 (6.0) 14 (3.5) 33 (8.7)
Ever had transactional sex 408 (52.1) 101 (25.1) 307 (80.6)
*

Two index participants were excluded due to data entry errors for the recruitment site.

**

One of the medication-assisted treatment (MAT) centers was also a public health center to which sexual partners of index participants were sent for HIV/HCV testing in the study.